Invesco CurrencyShares Australian Dollar Trust vs Invesco CurrencyShares Canadian Dollar Trust
FXA and FXC side by side, both in commodity contracts brokers and dealers. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FXA and FXC compare
Invesco CurrencyShares Australian Dollar Trust is the larger company, worth 1.3 times as much as Invesco CurrencyShares Canadian Dollar Trust ($98.3M against $75.4M).
On earnings, Invesco CurrencyShares Australian Dollar Trust is cheaper: it trades at 77.9× trailing earnings, against 762× for Invesco CurrencyShares Canadian Dollar Trust.
Invesco CurrencyShares Australian Dollar Trust grew revenue faster over the last twelve months (28.5% versus −51.9% for Invesco CurrencyShares Canadian Dollar Trust).
Invesco CurrencyShares Australian Dollar Trust keeps more of each dollar of sales as profit, with a net margin of 76.3% compared with 25.3% at Invesco CurrencyShares Canadian Dollar Trust.
Both pay dividends: Invesco CurrencyShares Australian Dollar Trust yields 1.1% and Invesco CurrencyShares Canadian Dollar Trust 0.11%.
Invesco CurrencyShares Australian Dollar Trust scores higher on the StockData Score (11 against 7 for Invesco CurrencyShares Canadian Dollar Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FXA | FXC |
|---|---|---|
| Size and price | ||
| Market cap | $98.3M | $75.4M |
| Share price | $67.81 | $68.59 |
| Change, 1 year | 4.8% | −1.6% |
| Change, 5 years | −5.6% | −11.4% |
| Beta (5Y) | 0.34 | 0.16 |
| StockData Score | ||
| Total score | 11 (better) | 7 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 1 | 1 |
| Valuation | ||
| P/E | 77.9× (better) | 762× |
| P/S | 62.0× (better) | 181× |
| PEG | – | 14.06 |
| Fair value | $23.65 | $6.29 |
| Margin of safety | −187% (better) | −991% |
| Growth | ||
| Revenue growth (TTM) | 28.5% (better) | −51.9% |
| Revenue growth, 5Y average | 69.6% (better) | 19.0% |
| Net income growth (TTM) | 28.3% (better) | −81.1% |
| EPS growth (TTM) | 3.6% (better) | −83.3% |
| Profitability | ||
| Net margin | 76.3% (better) | 25.3% |
| Financial health | ||
| Altman Z-score | 1929.01 | 2025.75 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% (better) | 0.11% |
| Payout ratio | 95.4% | 122% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 107% (better) | 19.8% |
| Shareholder yield | 1.1% (better) | 0.11% |
| Ownership | ||
| Held by institutions | 29.1% | 25.0% |
| Held by insiders | 0.00% | 0.00% |
| Short interest, % of float | 1.0% | 2.6% |
Go deeper
- FXA stock overview
- FXA income statement
- FXA valuation and score
- FXC stock overview
- FXC income statement
- FXC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.